Plumbagin reduces human colon cancer cell survival by inducing cell cycle arrest and mitochondria-mediated apoptosis

Eldhose,Binil; Gunawan,Mia; Rahman,Mahbubur; Latha,Mukalel  S.; Notario,Vicente

doi:10.3892/ijo.2014.2592

Plumbagin reduces human colon cancer cell survival by inducing cell cycle arrest and mitochondria-mediated apoptosis

Authors:
- Binil Eldhose
- Mia Gunawan
- Mahbubur Rahman
- Mukalel S. Latha
- Vicente Notario
View Affiliations

Affiliations: School of Biosciences, Mahatma Gandhi University, Kottayam, Kerala-686560, India, Department of Radiation Medicine, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20057, USA
Published online on: August 8, 2014 https://doi.org/10.3892/ijo.2014.2592
Pages: 1913-1920

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Despite increased use of early detection methods and more aggressive treatment strategies, the worldwide incidence of colorectal cancer is still on the rise. Consequently, it remains urgent to identify novel agents with enhanced efficacy in prevention and/or therapeutic protocols. Our studies focused on the use of Plumbagin, a natural phytochemical that showed promising results against other tumor types, to determine its effectiveness in blocking the proliferation and survival of colon cancer cells in experimental protocols mimicking the environment in primary tumors (attached culture conditions) and in circulating tumor cells (unattached conditions). Under both experimental settings, exposure of HCT116 cells to Plumbagin concentrations in the low micromolar range resulted in cell cycle arrest at the G1 phase, apoptosis via the mitochondrial cell death pathway, and increased production of reactive oxygen species. The cell cycle effects were more noticeable in attached cells, whereas the induction of cell death was more evident in unattached cells. These effects were consistent with the nature and the magnitude of the alterations induced by Plumbagin on the expression levels of a set of proteins known to play key roles in the regulation of cell cycle dynamics, apoptosis mechanisms and cell proliferation. In light of its previously reported lack of toxicity on normal colon cells and the striking anti-survival effect on colon cancer cells observed in our study, Plumbagin should be considered a promising drug for the treatment of colon cancer.

View Figures

View References

1	Arber N and Levin B: Chemoprevention of colorectal cancer; ready for routine use? Recent results. Cancer Res. 166:213–230. 2005.PubMed/NCBI
2	Siegel R, Naishadham D and Jamal A: Cancer statistics. CA Cancer J Clin. 62:10–29. 2012.
3	Mehta RG, Munillo G, Naithani R and Xinjian P: Cancer chemoprevention by natural products: how far have we come. Pharm Res. 27:950–961. 2010. View Article : Google Scholar : PubMed/NCBI
4	Frankfurt OS and Krishnan A: Apoptosis-based drug screening and detection of selective toxicity to cancer cells. Anticancer Drugs. 14:555–561. 2003. View Article : Google Scholar : PubMed/NCBI
5	Wang YC and Huang TL: Screening of anti-Helicobacter pylori herbs deriving from Taiwanese folk medicinal plants. FEMS Immunol Med Microbiol. 43:51–59. 2005.
6	Wang YC and Huang TL: Anti-Helicobacter pylori activity of Plumbago zeylanica L. FEMS Immunol Med Microbiol. 43:407–412. 2005.
7	Dai Y, Hou L, Cheng YP and But PP: Inhibition of immediate allergic reactions by ethanol extract from Plumbago zeylanica stems. Biol Pharm Bull. 27:429–432. 2004. View Article : Google Scholar : PubMed/NCBI
8	Chan-Bacab MJ and Pena-Rodriguez LM: Plant natural products with leishmanicidal activity. Nat Prod Rep. 18:674–688. 2001. View Article : Google Scholar : PubMed/NCBI
9	Krishnaswamy M and Purushothaman KK: Plumbagin: a study of its anticancer, antibacterial and antifungal properties. Indian J Exp Biol. 18:876–877. 1980.PubMed/NCBI
10	Sharma I, Gusain D and Dixit VP: Hypolipidaemic and anti-atherosclerotic effects of plumbagin in rabbits. Indian J Physiol Pharmacol. 35:59–63. 1991.
11	Parimala R and Sachdanandem P: Effect of plumbagin on some glucose metabolizing enzymes studied in rats in experimental hepatoma. Mol Cell Biochem. 125:10–14. 1996.
12	Naresh RA, Udupa N and Devi PU: Niosomal plumbagin with reduced toxicity and improved anticancer activity in BALB/C mice. J Pharmacol. 48:1128–1132. 1996. View Article : Google Scholar : PubMed/NCBI
13	Sugie S, Okamoto K, Rahman KM, et al: Inhibitory effects of plumbagin and juglone on azoxymethane-induced intestinal carcinogenesis in rats. Cancer Lett. 127:177–183. 1998.PubMed/NCBI
14	Srinivas P, Gopinath G, Banerji A, Dinakar A and Srinivas G: Plumbagin induces reactive oxygen species, which mediate apoptosis in human cervical cancer cells. Mol Carcinog. 40:201–211. 2004. View Article : Google Scholar : PubMed/NCBI
15	Kuo PL, Hsu YL and Cho CY: Plumbagin induces G2-M arrest and autophagy by inhibiting the AKT/mammalian target of rapamycin pathway in breast cancer cells. Mol Cancer Ther. 5:3209–3221. 2006. View Article : Google Scholar : PubMed/NCBI
16	Hsu YL, Cho CY, Kuo PL, Huang YT and Lin CC: Plumbagin induces apoptosis and cell cycle arrest in A549 cells through p53 accumulation via c-Jun NH2- terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo. J Pharmacol Exp Ther. 318:484–494. 2006. View Article : Google Scholar : PubMed/NCBI
17	Devi PU, Rao BS and Solomon FE: Effect of plumbagin on the radiation induced cytogenetic and cell cycle changes in mouse Ehrlich ascites carcinoma in vivo. Indian J Exp Biol. 36:891–895. 1998.PubMed/NCBI
18	Prasad VS, Devi PU, Rao BS and Kamath R: Radiosensitizing effect of Plumbagin on mouse melanoma cells grown in vitro. Indian J Biol. 34:857–858. 1996.PubMed/NCBI
19	Ganasoundari A, Zare SM and Devi PU: Modification of bone marrow radiosensitivity by medicinal plant extracts. Br J Radiol. 70:599–602. 1996. View Article : Google Scholar
20	Subramaniya BR, Srinivas G, Sadullah SSM, et al: Apoptosis inducing effect of Plumbagin on colonic cancer cells depends on expression of COX-2. PLoS One. 6:1–11. 2011. View Article : Google Scholar : PubMed/NCBI
21	Seyfried TN and Huysentruyt LC: On the origin of cancer metastasis. Crit Rev Oncog. 18:43–73. 2013. View Article : Google Scholar : PubMed/NCBI
22	Nguyen DX, Bos PD and Massagué J: Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer. 9:274–284. 2009. View Article : Google Scholar : PubMed/NCBI
23	Liotta LA and Kohn E: Anoikis: cancer and the homeless cell. Nature. 430:973–974. 2004. View Article : Google Scholar : PubMed/NCBI
24	Konstantopoulos K and Thomas SN: Cancer cells in transit: the vascular interactions of tumor cells. Annu Rev Biomed Eng. 11:177–202. 2009. View Article : Google Scholar : PubMed/NCBI
25	Jiang YL and Liu ZP: Natural products as anti-invasive and anti-metastatic agents. Curr Med Chem. 18:808–829. 2011. View Article : Google Scholar : PubMed/NCBI
26	Simon HU, Haj-Yehia A and Levi-Schaffer F: Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis. 5:415–418. 2000. View Article : Google Scholar : PubMed/NCBI
27	Circu ML and Aw TY: Reactive oxygen species, cellular redox systems and apoptosis. Free Radic Biol Med. 48:749–762. 2010. View Article : Google Scholar : PubMed/NCBI
28	Gupta SC, Kim JH, Prasad S and Aggarwal BB: Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev. 29:405–434. 2010. View Article : Google Scholar
29	Kaufmann SH and Earnshaw WC: Induction of apoptosis by cancer chemotherapy. Exp Cell Res. 256:42–49. 2000. View Article : Google Scholar : PubMed/NCBI
30	Lu JJ, Bao JL, Wu GS, et al: Quinones derived from plant secondary metabolites as anti-cancer agents. Anticancer Agents Med Chem. 13:456–463. 2013.PubMed/NCBI
31	Padhye S, Dandawate P, Yusufi M, Ahmad A and Sarkar FH: Perspectives on medicinal properties of Plumbagin and its analogs. Med Res Rev. 32:1131–1158. 2012. View Article : Google Scholar : PubMed/NCBI
32	Li J, Shen L, Lu FR, et al: Plumbagin inhibits cell growth and potentiates apoptosis in human gastric cancer cells in vitro through the NF-κB signaling pathway. Acta Pharmacol Sin. 33:242–249. 2012.PubMed/NCBI
33	Hafeez BB, Jamal MS, Fischer JW, Mustafa A and Verma AK: Plumbagin, a plant derived natural agent inhibits the growth of pancreatic cancer cells in vitro and in vivo via targeting EGFR, Stat3 and NF-κB signaling pathways. Int J Cancer. 131:2175–2186. 2012.PubMed/NCBI
34	Sinha S, Pal K, Elkhanany A, et al: Plumbagin inhibits tumorigenesis and angiogenesis of ovarian cancer cells in vivo. Int J Cancer. 132:1201–1212. 2013. View Article : Google Scholar : PubMed/NCBI
35	Abedinpour P, Baron VT, Chrastina A, Welsh J and Borgström P: The combination of Plumbagin with androgen withdrawal causes profound regression of prostate tumors in vivo. Prostate. 73:489–499. 2013. View Article : Google Scholar : PubMed/NCBI
36	Xu TP, Shen H, Liu LX and Shu YQ: Plumbagin from Plumbago zeylanica L induces apoptosis in human non-small cell lung cancer cell lines through NF-κB inactivation. Asian Pac J Cancer Prev. 14:2325–2331. 2013.
37	Sagar S, Esau L, Moosa B, Khashab NM, Bajic VB and Kaur M: Cytotoxicity and apoptosis induced by a Plumbagin derivative in estrogen positive MCF-7 breast cancer cells. Anticancer Agents Med Chem. 14:170–180. 2014. View Article : Google Scholar : PubMed/NCBI
38	Subramaniya BR, Srinivasan G, Sadullah SS, et al: Apoptosis inducing effect of plumbagin on colonic cancer cells depends on expression of COX-2. PLoS One. 6:e186952011. View Article : Google Scholar : PubMed/NCBI
39	Chen MB, Zhang Y, Wei MX, et al: Activation of AMP-activated protein kinase (AMPK) mediates plumbagin-induced apoptosis and growth inhibition in cultured human colon cancer cells. Cell Signal. 25:1993–2002. 2013. View Article : Google Scholar : PubMed/NCBI
40	Wu Y, Mehew JW, Heckman CA, Arcinas M and Boxer LM: Negative regulation of bcl-2 expression by p53 in hematopoietic cells. Oncogene. 20:240–251. 2001. View Article : Google Scholar : PubMed/NCBI
41	Mérino D, Giam M, Hughes PD, et al: The role of BH3-only protein Bim extends beyond inhibiting Bcl-2-like prosurvival proteins. J Cell Biol. 186:355–362. 2009.PubMed/NCBI
42	Sandur SK, Ichikawa H, Sethi G, Ahn KS and Aggarwal BB: Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) suppresses NF-κB activation and NF-κB-regulated gene products through modulation of p65 and IκBα kinase activation, leading to potentiation of apoptosis induced by cytokine and chemotherapeutic agents. J Biol Chem. 281:17023–17033. 2006.PubMed/NCBI
43	Nambiar D, Rajamani P and Singh RP: Effects of phytochemicals on ionization radiation-mediated carcinogenesis and cancer therapy. Mutat Res. 728:139–157. 2011. View Article : Google Scholar : PubMed/NCBI
44	Powolny AA and Singh SV: Plumbagin-induced apoptosis in human prostate cancer cells is associated with modulation of cellular redox status and generation of reactive oxygen species. Pharm Res. 25:2171–2180. 2008. View Article : Google Scholar : PubMed/NCBI
45	Checker R, Sharma D, Santosh SK, et al: Plumbagin inhibits proliferative and inflammatory response of T cells independent of ROS generation but by modulating intracellular thiols. J Cell Biochem. 110:1082–1093. 2011. View Article : Google Scholar